Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BCA Research Analyst: Currently, all typical top signals have appeared in the cryptocurrency market

BCA Research Analyst: Currently, all typical top signals have appeared in the cryptocurrency market

Bitget2025/02/11 14:11

According to Jinshi News, a team led by Juan Correa, Global Asset Allocation Strategist at BCA Research, stated that the cryptocurrency market has now shown all typical top signals, including two low-circulation meme coins personally launched by Trump. They believe that Trump's coin issuance behavior "indicates a desire for personal wealth growth rather than sharing profits with new buyers."

Although institutional investors do not hold meme coins and according to BCA's calculations, meme coins account for less than 2% of the entire cryptocurrency market, strategists say that the surge in meme coins is a precursor to a larger trend: The market consensus on cryptocurrencies has become very optimistic; Bitcoin ETFs have become the most successful ETF issuances in history; BlackRock CEO Larry Fink said large investors are discussing whether to allocate 5% of their portfolios to Bitcoin. Fink even predicted that bitcoin prices could rise to $700k.

The BCA team stated: "We worry this frenzied optimism is a signal indicating that the cryptocurrency market is nearing its peak." They pointed out that currently more than 90% of Bitcoin supply is profitable - historically this ratio usually signifies when Bitcoin price peaks. They also added that eight out of ten financial apps ranked in download volume are crypto trading apps. In addition, the BCA team mentioned macroeconomic concerns including deficit spending possibly being lower than expected. “If US economy turns colder than expected and government acts irresponsibly fiscally it will be unfavorable for bitcoin continuing its explosive rally.” they said if bitcoin price falls down to $75k they would “buy more aggressively”. They also noted if Trump pushes forward plans establishing strategic reserves for bitcoins it might pose risk against their view point “Bitcoin price has peaked”.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

South Korean think tanks significantly raise 2027 economic growth forecasts, betting on continued AI chip boom

The Korea Development Institute (KDI) raised its economic growth forecast for this year and next on Wednesday, betting that the global artificial intelligence (AI) boom will continue to drive semiconductor exports and investment, helping the South Korean economy maintain its growth momentum.

智通财经•2026/11/18 04:12

SQM.US Q3 profit misses expectations; lithium price declines but demand outlook remains “encouraging”

SQM.US still reports seeing "encouraging" potential demand trends.

智通财经•2026/11/18 03:16

Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.

According to a report by Mizuho Securities analysts, following a series of recent system failures in the United States, consumers have started stockpiling essential goods, leading to a short-term surge in demand for Costco, a members-only retailer.

智通财经•2026/11/18 03:07
Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.

Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years

Biogen has released the latest interim clinical trial data for its early-stage Alzheimer's disease candidate drug, diranersen.

智通财经•2026/11/18 03:02
Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years